trending Market Intelligence /marketintelligence/en/news-insights/trending/DXpxHnsZbywckVjm-GCTWg2 content esgSubNav
In This List

Microbot Medical names director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Microbot Medical names director

Microbot Medical Inc. appointed P. Laxminarain to its board.

Laxminarain will succeed Moshe Shoham, who left the board to focus more of his time on the scientific side of the company.

Laxminarain has over 30 years of experience in the medical device field. He was most recently worldwide president of Codman Neurosurgery, a Johnson & Johnson division acquired by Integra LifeSciences Holdings Corp. in October.